SIK1/Snf1lk Antibody Blocking Peptide

• Reactivity: Hu
• Applications: AC
• Concentration: 0.2 mg/ml

SIK1/Snf1lk Antibody Blocking Peptide Summary

• Description: A blocking peptide containing 18 amino acids near the center of human SIK1.

  Source: Synthetic

  (Accession #: NP_775490)

• Source: Synthetic
• Protein/Peptide Type: Antibody Blocking Peptide
• Gene: SIK1
• Purity: N/A

Applications/Dilutions

• Dilutions:
  • Antibody Competition
• Application Notes: This peptide is useful as a blocking peptide for NBP1-76571.
  
  For further blocking peptide related protocol, click here.

Packaging, Storage & Formulations

• Storage: Store at -20C. Avoid freeze-thaw cycles.
• Buffer: PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin.
• Preservative: 0.02% Sodium Azide
• Concentration: 0.2 mg/ml
• Purity: N/A

Alternate Names for SIK1/Snf1lk Antibody Blocking Peptide

• EC 2.7.11
• EC 2.7.11.1
• msk
• myocardial SNF1-like kinase
• salt-inducible kinase 1
• Salt-inducible protein kinase 1
• serine/threonine protein kinase
• serine/threonine-protein kinase SIK1
• Serine/threonine-protein kinase SNF1-like kinase 1
• Serine/threonine-protein kinase SNF1LK
• SIK
• SIK1
• SIK-1
• SIK1/Snf1lk
• SNF1-like kinase
• SNF1LK
• SNF1LKMSK

Background

Transient role during the earliest stages of myocardial cell differentiation and/or primitive chamberformation and may also be important for the earliest stages of skeletal muscle growth and/or differentiation.Potential role in G2/M cell cycle regulation. Inhibits CREB activity by phosphorylating and repressing theCREB-specific coactivators, CRTC1-3

Limitations

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Peptides and proteins are guaranteed for 3 months from date of receipt.

Bioinformatics

• Gene Symbol: SIK1